by Manoranjan Das | Jan 26, 2026 | Featured
In the past, pharmaceutical companies have invested heavily in Next Best Action (NBA) initiatives—rule engines, propensity models, dashboards, and AI-driven recommendations to improve field force effectiveness. Yet the gap persists. Field teams still struggle with...
